APA (7th ed.) Citation

Ishiguro, N., Morioka, I., Nakano, T., Furukawa, M., Tanaka, S., Kinoshita, M., & Manabe, A. (2021). Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: An open-label, randomized, active-controlled trial protocol. BMC infectious diseases, 21(1), 1-10. https://doi.org/10.1186/s12879-021-06494-w

Chicago Style (17th ed.) Citation

Ishiguro, Nobuhisa, Ichiro Morioka, Takashi Nakano, Masashi Furukawa, Shintaro Tanaka, Masahiro Kinoshita, and Atsushi Manabe. "Clinical and Virological Outcomes with Baloxavir Compared with Oseltamivir in Pediatric Patients Aged 6 to < 12 years with Influenza: An Open-label, Randomized, Active-controlled Trial Protocol." BMC Infectious Diseases 21, no. 1 (2021): 1-10. https://doi.org/10.1186/s12879-021-06494-w.

MLA (9th ed.) Citation

Ishiguro, Nobuhisa, et al. "Clinical and Virological Outcomes with Baloxavir Compared with Oseltamivir in Pediatric Patients Aged 6 to < 12 years with Influenza: An Open-label, Randomized, Active-controlled Trial Protocol." BMC Infectious Diseases, vol. 21, no. 1, 2021, pp. 1-10, https://doi.org/10.1186/s12879-021-06494-w.